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Summary Several lines of evidences suggest that the brain-derived neutrophic factor (BDNF) is
implicated in the pathophysiology of depression. However, the molecular mechanisms are not
fully understood. In the current study we aimed to investigate how genetic modulation of BDNF in
the hippocampus using microRNa124a (miR124a)-expressing lentiviral vectors (LV) might affect
depression-like behavior in adult rats. For this purpose, we assessed the expression level of
miR124a and its direct target BDNF in the hippocampus and the cortex after 21-days exposure to
social defeat stress. Results demonstrated that miR124a was up-regulated in the hippocampus but
not in the cortex. In contrast, and as expected, BDNF transcripts were down-regulated. In a
different set of experiments, male Wistar rats received bilateral intra-hippocampal or intra-
cortical infusions of BDNF- and miR124a-expressing lentiviral vectors and depression-like behavior
was assessed after 21-days social defeat stress using the novelty suppressed feeding, the sucrose
preference and the forced swim tests. The results indicated that miR124a overexpression
exacerbated depression-like behavior. However, an anti-depressant like effect was observed
when BDNF or miR124a-silencers (siR124a) were injected into the hippocampus. Importantly,
when expressed into the cortex, LV-miR124a, LV-siR124a and LV-BDNF had no effect on depression.
Our ﬁndings indicate that hippocampal miR124a and its direct target BDNF play an important role
in depression-like behavior. Taken together, the current results reveal, for the ﬁrst time, a
potential molecular regulation of miR124a on BDNF, and the pronounced behavioral consequences
of this regulation shed light on the mechanisms underlying BDNF anti-depressant potential.
# 2014 Elsevier Ltd. All rights reserved.
Abbreviations: BDNF, brain-derived neurotrophic factor; FST, forced swim test; Hipp, hippocampus; LV, lentiviral vector; miRNA, microRNA;
NSFT, novelty suppressed feeding test; SPT, sucrose preference test.
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1. Introduction
Depression is a prevalent, highly debilitating mental disorder
affecting up to 15% of the population at least once in their
lifetime, with huge costs for society. Neurobiological
mechanisms of depression are still not well known, although
there is consensus about interplay between genetic and
environmental factors (Masi and Brovedani, 2011). Antide-
pressant medications are frequently used in depression, but
at least 50% of patients are poor responders, even to more
recently discovered medications. There is a clear evidence
for altered endocrine factors and metabolic dysregulation in
mood disorders (Hendrickx et al., 2005). However, clinical
response only occurs following weeks to months of treatment
and only chronic treatment is effective (Masi and Brovedani,
2011), suggesting that actions beyond the rapidly occurring
effect of enhancing monoaminergic systems, such as adapta-
tion of these systems, are responsible for the effects of
antidepressants.
Recent studies have shown that certain aspects of depres-
sion result from maladaptive stress-induced neuroplastic
changes in speciﬁc neural circuits of the CNS (Nestler
et al., 2002). These studies emphasize that neuronal plas-
ticity plays an important role in the recovery from depres-
sion and they indicate that an impairment of synaptic
plasticity, particularly in the hippocampus, may be a core
factor in the pathophysiology of depression. The abnormal
neural plasticity may be related to alterations in the levels of
neurotrophic factors, namely brain-derived neurotrophic
factor (BDNF), which play a central role in plasticity. As
BDNF is repressed by stress, epigenetic regulation of the
BDNF gene may play an important role in depression (Masi
and Brovedani, 2011). In turn as a treatment, antidepressant
drugs and electroconvulsive shock treatment increase the
expression of BDNF and its receptor TrkB (Castren and Ran-
tamaki, 2010).
Neurotrophins constitute a family of proteins that stimulate
and control neurogenesis during development and BDNF is
among the most active (Zigova et al., 1998). BDNF plays a
key role on the central and peripheral nervous system to
support the survival of existing neurons, and to induce
neurogenesis and stimulate synaptic plasticity and synapto-
genesis (Acheson et al., 1995). It is mainly active in brain
areas vital to learning, memory, and higher thinking, including
the hippocampus, the cortex, and basal forebrain (Yamada
and Nabeshima, 2003). In addition, BDNF regulates synaptic
plasticity in neuronal networks involved in several brain
disorders including bipolar disorder, as well as schizophrenia,
obsessive—compulsive disorder, Alzheimer’s disease, Hun-
tington’s disease, Rett syndrome, and dementia (Schinder
and Poo, 2000). Furthermore, stress exposure decreases the
expression of BDNF, and, if exposure is persistent, this leads
to an eventual atrophy of the hippocampus, which also takes
place in humans suffering from chronic depression. In turn,
regulation of BDNF may reverse stress-induced deﬁcits in
structural and synaptic plasticity in the brain, yielding
increased ability to cope with environmental challenges
that may precipitate or exacerbate depressive episodes
(Castren and Rantamaki, 2010). Low BDNF and depression
are most probably causally related, since antidepressants
indeed increase BDNF signaling and synthesis in the hippo-
campus (Schmidt and Duman, 2010). Although it is now
ﬁrmly established that BDNF signaling plays an important
role in the mechanism of action of antidepressant drugs, yet
the role of BDNF in the pathophysiology of depression is less
clear (Castren and Rantamaki, 2010). Furthermore, there is
strong evidence that peripheral growth factors, including
BDNF, pro-inﬂammatory cytokines, endocrine factors, and
metabolic markers contribute to the pathophysiology of
major depressive disorder and antidepressant response
(Schmidt et al., 2011). As a matter of fact BDNF levels
are decreased in the blood of depressed patients and can
be normalized with successful antidepressant treatment
(Sen et al., 2008), although the origin and role of serum
BDNF is unclear (Karege et al., 2005). Chronic peripheral
administration of BDNF produces antidepressant and anxio-
lytic behavioral responses in animal models, increases the
survival rate of newborn neurons, and increases BDNF-
mediated signaling in the adult hippocampus (Schmidt
and Duman, 2010), an evidence that peripheral BDNF has
functional actions within the brain and on behavior, and that
serum BDNF may be a relevant biomarker for depression and
treatment response.
Neurotrophin BDNF acts via its receptor Tropomyosin-
related kinase B receptor (TrkB or p75), promoting intracel-
lular signaling that is yielding to protein synthesis (Soppet
et al., 1991). The induction of protein synthesis by BDNF
critically contributes to enduring modiﬁcations of synaptic
function, but how BDNF selectively affects only a minority
of expressed mRNAs is poorly understood. It has been estab-
lished that BDNF rapidly elevates Dicer, increasing mature
microRNAs (miRNA) levels and inducing RNA processing
bodies in neurons (Huang et al., 2012).
MiRNAs are small non-coding RNAs of about 22-nucleotides
in length regulating gene expression at post-transcriptional
level that act as key regulators of all cellular pathways
(Treiber et al., 2012). After transcription, the mature miRNA
is incorporated into a miRNA—protein complex, where it
directly interacts with a member of the Argonaute protein
family. The miRNA guides such protein complexes to partial
complementary target sites, which are typically located in
the 30 untranslated region (UTR) of mRNAs leading to inhibi-
tion of gene expression. MiRNA activity and abundance is
regulated on various levels ranging from transcription and
processing to target site binding and miRNA stability (Treiber
et al., 2012). A single miRNA may speciﬁcally regulate gene
expression of over hundred different targets. Among them,
miR124a is strongly expressed in the brain; miR124a regulates
adult neurogenesis (Cao et al., 2007), and promotes neuronal
differentiation (Makeyev et al., 2007) and it is involved in
several brain disorders (Qi et al., 2012). In addition, miR124a
also strongly affects the expression of several neurotrans-
mitters, including mainly BDNF (Bahi and Dreyer, 2013; Chan-
drasekar and Dreyer, 2009, 2011). This prompted us to
investigate the potential role of miR124a in the ethiology
of depression.
For this purpose, in this study we assessed the expression
levels of miR124a and its direct target BDNF in the rat brain
following exposure to 21-days social defeat stress. In addi-
tion, our major goal in the present studies was to examine
the effects of lentiviral-mediated genetic modulation of
BDNF and miR124a in male Wistar rats on performance in
three behavioral tests following exposure to chronic social
defeat stress.
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2. Materials and methods
2.1. Animals
Experimental male Wistar rats (200 g) were single-housed
in standard plexiglas cages at a room temperature of
approx. 22 8C with a 12 h/12 h light/dark cycle and
allowed to adapt to this environment for a period of 7-
days before the experiments began. All rats were bred in
the local central animal facility of the CMHS and were kept
under standard laboratory conditions. Bedding was pro-
duced locally and autoclaved before use and rats had free
access to tap water and standard rodents chow diet
obtained from the National Feed and Flour Production
and Marketing Company LLC (Abu Dhabi, UAE). All the
experimental procedures were approved by the institu-
tional Research Ethics Committee (Protocol No A17-12).
2.2. Tissue collection and quantiﬁcation of BDNF
and miR124a after social defeat stress
Brains from decapitated control and stressed rats were
rapidly removed and brain regions (whole cerebral cortex
and hippocampus) were dissected out on ice. Tissue samples
were immediately frozen in TRizol and stored at 80 8C until
analysis. The micro-dissection procedure was performed
according to rat stereotaxic coordinates (Paxinos and Wat-
son, 1998).
Reactions were essentially carried out as described
previously (Bahi and Dreyer, 2013; Chandrasekar and
Dreyer, 2009). In brief, total RNA from brain regions was
isolated using the TRizol according to the manufacturer
instructions. Total RNA (5 mg per sample) was reverse
transcribed using Oligo-dT standard primers. For qPCR,
20 ml of ampliﬁcation mixture with SYBRGreen Kit was
used containing 3 ml of cDNA and 100 nM primers. Primer
sequences used were: GAPDH: 50-ATG ACT CTA CCC ACG
GCA AG-30 and 50-CAT ACT CAG CAC CAG CAT CAC-30;
miR124a: 50-TCC GTG TTC ACA GCG GAC-30 and 50-CAT
TCA CCG CGT GCC TTA-30 and BDNF: 50-GGT TCG AGA
GGT CTG ACG AC-30 and 50-CAA AGG CAC TTG ACT GCT
GA-30 (Bahi et al., 2008a; Bahi and Dreyer, 2013). The PCR
protocol used consisted of a 45-s denaturation at 94 8C
followed by 45-s annealing and extension at 64 8C for 40
cycles.
2.3. Lentiviral constructions and production
Our lentivirus derived plasmid (pTK431), driven by the cyto-
megalovirus (CMV) promoter, carried the transgenes for
BDNF, miR124a or siR124a described in our previous studies
(Bahi et al., 2008a; Bahi and Dreyer, 2013; Chandrasekar and
Dreyer, 2009). The empty vector (LV-Mock) was used as
negative control. All constructions were conﬁrmed by
sequencing. Viral vector generation was obtained by co-
transfection of HEK293T cells by the calcium phosphate
method on 10-cm plates with 20 mg of pTK431, 15 mg of
pDNRF, and 5 mg of pMDG-VSV-G. The supernatant was har-
vested 24 and 72 h after infection and viral particles were
puriﬁed by ultracentrifugation (Bahi et al., 2005, 2008b).
2.4. Stereotaxic injection of LV-BDNF, LV-Mock,
LV-miR124a and LV-siR124a
For stereotaxic  surgery, rats were anesthetized with a
ketamine/xylazine mixture (100 mg/kg and 10 mg/kg
respectively, i.p.) and installed in a stereotaxic frame.
Using a precision Hamilton micro-syringe with a 26 G
needle, rats were bilaterally infused with 1 ml viral solu-
tion using the following coordinates: hippocampus [1st
injection: 4.8 mm posterior to Bregma, 2.5 mm lateral
the medial suture, 3.5 mm ventral to the skull surface. 2nd
injection: 4.8 mm posterior to Bregma, 5 mm lateral the
medial suture, 6 mm ventral to the skull surface]. Cortex
[1st injection: 2.2 mm anterior to Bregma, 3 mm lateral
the medial suture, 2 mm ventral to the skull surface. 2nd
injection: 2.2 mm anterior to Bregma, 4.5 mm lateral
the medial suture, 4 mm ventral to the skull surface].
All viral-injections were performed according to the rat
stereotaxic coordinates (Paxinos and Watson, 1998). Rats
were left to recover for 7 days before being exposed to the
social defeat stress procedure. After recovery and in the
1st set of experiments, we ended up with 19 rats that were
injected into the hippocampus (LV-Mock n = 9, LV-BDNF
n = 10) and 16 rats that were injected into the cortex
(LV-Mock n = 8, LV-BDNF n = 8). In the 2nd set of experiment
we ended up with 24 rats that were injected into the
hippocampus (LV-Mock n = 7, LV-miR124a n = 9, siR124a
n = 8) and 20 rats that were injected into the cortex
(LV-Mock n = 6, LV-miR124a n = 7, siR124a n = 7).
2.5. Social defeat stress
The social defeat stress model of depression was based on the
resident-intruder paradigm (Korte et al., 1990). In brief,
experimental-rats were exposed to a large dominant adult
(400 g) male Wistar aggressor rat for 30 min each day over a
total of 21 days. After contact, the experimental-rat was
separated from the aggressor resident-rat using a cage that
was divided into two parts by a perforated divider. Thus, the
experimental-rat and the resident-rat were maintained in
visual and sensory contact for the next 24 h without physical
contact. Every 4th day the experimental-rat was exposed to a
new aggressor. Resident aggressor rats were selected for
their level of aggressiveness by counting the latency to attack
a naive Wistar rat (maximum 2 min delay). To promote their
aggressive behavior, the resident-rats were housed with
females 10 days prior to the social defeat stress test to
ensure that they accept and defend their cage as home cage
(territory).
2.6. Depression-like behavioral tests
2.6.1. Novelty suppressed feeding (NSF) test
The novelty suppressed feeding procedure was performed as
described previously (Bahi and Dreyer, 2012). In brief, 24 h
prior to testing, rats were deprived of food but not water. On
the test day, each rat was introduced into a white plastic
open arena (32 cm  32 cm) covered with wood-chip bed-
ding, and on which center several pellets of food were put on
a circular paper. The latency to bite the food pellet was
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measured as the test main parameter. Immediately after the
animal commenced eating, the rat was immediately removed
from the testing box and returned to its home cage with
access to food. Therefore, the total pellet consumption was
measured for a further 90 min period in order to evaluate
home cage food intake.
2.6.2. Sucrose preference test (SPT)
For the SPT, a two-bottle choice procedure was used to test
for differences between the groups for their relative pre-
ference for sucrose over water. The rats were given free
choice between 2% sucrose-solution and tap water for 24 h.
One week before starting, experimental-rats had been habi-
tuated to two-bottle choice conditions and the position of the
bottles was switched after every 24 h to prevent any side
preference in drinking behavior. No previous food or water
deprivation was applied before the test. Preference was
measured as follows: (i) sucrose consumption (ml); (ii) water
consumption (ml); and (iii) total liquid (sucrose + water). At
the end of the test, the bottles were removed and the
consumption was noted. The preference for sucrose was
calculated as percentage of consumed sucrose-solution to
the total amount of liquid drunk (Hennebelle et al., 2012;
Zurita et al., 1996).
2.6.3. Forced swim test (FST)
The FST was performed according to the method originally
reported by Porsolt and colleagues (Porsolt et al., 1977) and
this procedure was successfully used in the laboratory in our
previous studies (Bahi and Dreyer, 2012). In brief, glass beakers
were ﬁlled with tap water (22—26 8C). Rats were placed into
the test beaker and were unable to escape or rest by touching
the bottom of the beaker. The cylinders were emptied and
cleaned between rats. Sessions lasted 6 min and the following
behavioral parameters were measured: immobility, swimming
and climbing. Immobility was deﬁned as the absence of all
motions except those required for keeping the rat’s head
above water. The swimming behavior was considered if a rat
was actively making swimming movements that caused it to
move within the center of the cylinder. The climbing behavior
was recorded if a rat was making forceful thrashing movements
with its forelimbs against the walls of cylinder. The data are
expressed as the mean time (SEM) of immobility, swimming
and climbing within the 360-s observation period.
Figure 1 Effect of chronic social defeat on (A) BDNF and (B) miR124a expression in the rat hippocampus and cortex. Expression levels
were normalized against GAPDH in the corresponding samples. Histograms represent mean  SEM, n = 6. *Signiﬁcant differences
between control and stress ( p < 0.05). #Signiﬁcant differences between the hippocampus and the cortex ( p < 0.05) (two-way ANOVA,
Bonferroni’s post hoc test), (C) effect of lentiviral injection on BDNF mRNA expression in the dorsal DG, ventral DG and the CA1/CA3.
Expression levels were normalized against GAPDH in the corresponding samples. Histograms represent mean  SEM, n = 7. *Signiﬁcant
differences between LV-Mock and LV-miR124a ( p < 0.05). **Signiﬁcant differences between LV-Mock and LV-siR124a ( p < 0.001) (two-
way ANOVA, Bonferroni’s post hoc test) and (D) schematic representation of the experimental procedures. The timeline shows
sequence and duration of experimental protocols of the effect of viral injection on chronic social defeat-induced depression-like
behavior.
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2.7. Statistical analysis
For statistical comparisons, the software package SPSS (ver-
sion 20.0) was used. All data were expressed as means  SEM.
BDNF and miR124a mRNA expression was analyzed using a
two-way analysis of variance (ANOVA) with treatment (con-
trol vs. stress) and region (hippocampus vs. cortex) as the
between subject factors. Data obtained from the behavioral
tests were analyzed using a two-way ANOVA with virus and
region as the between subject factors. Post hoc individual
mean comparisons were performed with the Bonferroni’s test
when F values were signiﬁcant. The level of statistical sig-
niﬁcance was set at p < 0.05 at all times.
3. Results
3.1. Effects of social defeat stress on brain
expression of BDNF and miR124a
Fig. 1 shows the effects of chronic social defeat stress on the
expression of BDNF in the hippocampus and the cortex
detected by RT-PCR. As shown in Fig. 1A, 21-days social defeat
stress caused a signiﬁcant down regulation (4 folds) of BDNF
mRNA in the hippocampus but not in the cortex. A two-way
ANOVA revealed a main effect of stress (F(1,20) = 4.027,
p = 0.058); but the main effect of brain region was not sig-
niﬁcant (F(1,20) = 1.533, p = 0.230). Nevertheless, the interac-
tion between stress and brain region was signiﬁcant
(F(1,20) = 10.926, p = 0.004). These ﬁndings demonstrated that
3 weeks of social defeat stress in rats down-regulated hippo-
campal, but not cortical, BDNF mRNA expression.
Fig. 1B shows the miR124a expression levels in the inves-
tigated brain regions hippocampus and cortex. All data are
means  SEM of the particular brain specimens from the con-
trol (n = 6) and socially defeated (n = 6) groups of rats. Results
show that miR124a is expressed in each of the investigated
brain regions, although at different levels. In fact, social
defeat stress produced a signiﬁcant increase (2 folds) of
miR124a in the hippocampus but not in the cortex. Two-way
ANOVA indicated that the individual [stress: (F(1,20) = 8.689,
p = 0.008); brain region (F(1,20) = 3.446, p = 0.078)] and
interactive (F(1,20) = 4.784, p = 0.041) effects of stress and
brain regions were statistically signiﬁcant. These results
indicated that 3-weeks of social defeat stress in rats increased
miR124a expression into the hippocampus, but not into
the cortex.
In order to provide more convincing evidence that BDNF
was directly regulated by miR124A, rats were stereotaxically
injected with LV-Mock, LV-miR124a or LV-siR124a in the hip-
pocampus and BDNF mRNA was quantiﬁed using RT-PCR. The
regions chosen to quantify BDNF expression were the dorsal
and ventral dentate gyrus (DG) and the CA1/CA3 region. As
depicted in Fig. 1C, two-way ANOVA analysis with virus and
sub-region as the between subject factors revealed a sig-
niﬁcant effect of viral injection (F (2,54) = 28.992, p < 0.0001)
but no effect of sub-region was detected (F(2,54) = 1.653,
p = 0.205). Nevertheless, the interaction between the two
factors was signiﬁcant (F(4,54) = 7.297, p < 0.001). Post hoc
evaluations revealed that LV-miR124a and LV-siR124a only
affected BDNF expression in the dorsal DG as well as in the
CA1/CA3 sub-regions but not in the ventral DG.
Based on these ﬁndings we decided to investigate the
potential protective role of BDNF and miR124a-silencers
overexpression into the hippocampus on social defeat
stress-induced depression-like behavior in rats. The experi-
mental timeline is depicted in Fig. 1D.
3.2. Effects of BDNF overexpression on social
defeat stress-induced depression
The novelty-induced suppression of feeding (NSF) test
assesses depression- and anxiety-like phenotypes by measur-
ing the latency of rats to eat food in a novel anxiogenic open
ﬁeld following food deprivation (Bodnoff et al., 1989). Rats
were stereotaxically injected into the hippocampus or into
the cortex and exposed to the social defeat stress 7 days later
as described in Section 2. We should emphasize that one rat
from each group was removed from the analysis as they
escaped from the arena. Therefore the group sizes were:
hippocampus (LV-Mock n = 8, LV-BDNF n = 10); cortex (LV-
Mock n = 8, LV-BDNF n = 7). Using a two-way ANOVA test
we found a signiﬁcant effect of virus for the latency to bite
a food pellet at the center of the arena, with the hippo-
campus BDNF-injected group having a signiﬁcantly shorter
latency to feed [main effect of virus: (F (1,29) = 13.704,
p = 0.001); main effect of brain region: (F (1,29) = 11.558,
p = 0.002)]. More importantly, the interaction between
the two factors was signiﬁcant (F (1,29) = 9.918, p = 0.004)
(Fig. 2A). In addition and as depicted in Fig. 2B, BDNF rats did
not differ from Mock-injected rats in their food intake in the
home cage during a 90-min period immediately following
the latency test [main effect of virus: (F (1,29) = 0.082,
p = 0.776); main effect of brain region: (F (1,29) = 0.048,
p = 0.829); interaction between virus and brain region:
(F (1,29) = 0.254, p = 0.618)]. Finally, both Mock- and BDNF-
overexpressing groups did not differ in the amount of
weight lost during the 24 h food deprivation period (data
not shown). These ﬁndings strongly suggest that reduced
latency to feed was directly related to lower anxiety levels in
the hippocampus, but not the cortex, of BDNF-overexpres-
sing rats.
In order provide an appreciation of the precise magnitude
of the stressors alone on the various behavioral tests and how
the various lentiviral treatments alone affected these tests,
we performed a further experiment using non-stressed con-
trol group that is given the various lentiviral treatments in
the hippocampus (not the cortex) and then subsequently
tested (Supplementary Fig. 1). It should be emphasized that
the data with non-stress controls and stress animals are a
combination of separate experiments, which is far from the
optimal design.
Rats were then assessed in the sucrose preference test
(SPT). This is a model of anhedonia, a core symptom of
depression, in which rats fail to elicit pleasure from an
activity that is normally enjoyable (Soﬁa and Knobloch,
1976). The groups of rats used were as follow: hippocampus
(LV-Mock n = 9, LV-BDNF n = 10); cortex (LV-Mock n = 8, LV-
BDNF n = 8). The SPT scores are shown in Fig. 2C and these
data follow the same pattern as the NSF test data. In fact, a
two-way ANOVA revealed that lentiviral-mediated overex-
pression of BDNF in the hippocampus, but not in the cortex,
increased sucrose preference. Indeed, there was signiﬁcant
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main effect of brain region (F(1,31) = 8.897, p = 0.006) and
viral injection (F (1,31) = 4.856, p = 0.035). More importantly,
the interaction between viral-injection and the brain region
was signiﬁcant (F (1,31) = 10.433, p = 0.003). As a possibly
confounding variable for anhedonia, total ﬂuid intake was
also tested and results are depicted in Fig. 2D. The two-way
ANOVA analysis revealed that there was no main effect of
viral injection (F (1,31) = 1.170, p = 0.288) nor brain region
(F (1,31) = 0.169, p = 0.863) on total ﬂuid intake. Interestingly,
the interaction between viral-injection and brain region was
not signiﬁcant (F(1,31) = 0.104, p = 0.749). The experiments
using the non-stressed control groups are shown in Supple-
mentary Fig. 2. The data with non-stress controls and stress
animals are a combination of separate experiments, which is
far from the optimal design.
After completion of the SPT, rats were tested in the
Forced swim test (FST) 48-h later and results are depicted
in Fig. 3. The groups of rats used were as follow after
removing 3 rats because of diving: hippocampus (LV-Mock
n = 8, LV-BDNF n = 9); cortex (LV-Mock n = 7, LV-BDNF n = 8).
Two-way ANOVA analysis revealed that BDNF overexpression
in the hippocampus, but not in the cortex, signiﬁcantly
decreased the time of immobility (2.5 fold) [main effect
of brain region: (F (1,28) = 4.820, p = 0.037), main effect of
viral-injection (F (1,28) = 3.849, p = 0.060), the main effect of
brain region  virus interaction (F (1,28) = 6.147, p = 0.019)]
(Fig. 3A). Consequently  and as expected, when injected into
the hippocampus, but not into the cortex, BDNF signiﬁcantly
increased the time the rats spent swimming [main effect of
brain region: (F (1,28) = 4.217, p = 0.049), main effect of
viral-injection (F (1,28) = 2.847, p = 0.103), the main effect
of the interaction between the viral-injection and the brain
region (F (1,28) = 7.607, p = 0.010)] (Fig. 3B). The experi-
ments using the non-stressed control groups are shown in
Supplementary Fig. 3. The data with non-stress controls and
stress animals are a combination of separate experiments,
which is far from the optimal design.
Our present data indicate that lentiviral-mediated over-
expression of BDNF into the hippocampus, but not into the
cortex, induces reduction of immobility and enhancement in
the swimming time in the FST in rats following chronic social
defeat stress.
3.3. Effects of miR124a overexpression and
silencing on social defeat stress-induced
depression-like behavior in rats
To test the effects of miR124a on social defeat stress-
induced depression like behavior in Wistar rats, both gain-
and loss-of-function approaches were used. In these
experiments, LV-siR124a was used to knock down its expres-
sion and a lentivirus expressing miR124a (LV-miR124a) was
used to up-regulate its expression in the hippocampus or into
the cortex. Empty vector was used as a negative control
(LV-Mock).
Rats were ﬁrst tested in the NSF test and results are
depicted in Fig. 4. The groups of rats used were as follow:
hippocampus (LV-Mock n = 7, LV-miR124a n = 8, siR124a
n = 7); cortex (LV-Mock n = 6, LV-miR124a n = 7, siR124a
n = 7). Two-way ANOVA analysis has shown that the latency
to feed varied as a function of virus (F (2,38) = 13.932,
p < 0.001) but not brain region (F(1,38) = 1.402, p = 0.460).
Nevertheless, the interaction between viral-injection and
the brain region was signiﬁcant (F(2,38) = 7.969, p = 0.001)
(Fig. 4A). Post hoc evaluations revealed that, compared to
Figure 2 Effect of lentiviral-mediated BDNF overexpression on
chronic social defeat-induced depression-like behavior in the
novelty suppressed feeding (NSF) and sucrose preference test
(SPT). (A) Eating delay as measured by the latency to bite food in
a novel anxiogenic environment following 24-h food deprivation,
(B) food intake of rats in the home cage during a 90 min period
following NSF latency test, (C) sucrose preference was calculat-
ed by the following formula: preference = (sucrose solution
intake/total ﬂuid intake)  100, and (D) total ﬂuid intake su-
crose intake + water intake. *Signiﬁcant differences between
Mock and BDNF ( p < 0.05). #Signiﬁcant differences between
the hippocampus and the cortex ( p < 0.05) (two-way ANOVA,
Bonferroni’s post hoc test). Hippocampus (LV-Mock n = 9, LV-
BDNF n = 10); cortex (LV-Mock n = 8, LV-BDNF n = 8).
Figure 3 Effect of lentiviral-mediated BDNF overexpression on
chronic social defeat-induced depression-like behavior in the
forced-swim test (FST). (A) Immobility and (B) swimming. *Sig-
niﬁcant differences between Mock and BDNF ( p < 0.05). #Signif-
icant differences between the hippocampus and the cortex
( p < 0.05) (two-way ANOVA, Bonferroni’s post hoc test). Hippo-
campus (LV-Mock n = 9, LV-BDNF n = 10); cortex (LV-Mock n = 8,
LV-BDNF n = 8).
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controls (LV-Mock), rats injected with miR124a showed a ca.
1.5-fold increased latency to approach the food pellet
( p = 0.028). More importantly and as expected, silencing
miR124a expression into the hippocampus, but not into the
cortex, using siR124a drastically reduced the latency to feed
( p = 0.034 and p < 0.001 vs. Mock and miR124a respec-
tively). In addition and as depicted in Fig. 4B, the three-
groups of rats did not differ in their food intake in the home
cage during a 90 min period immediately following the
latency test [main effect of brain region: (F (1,38) = 0.243,
p = 0.625); main effect of viral-injection: (F (2,38) = 0.179,
p = 0.837); interaction between virus and brain region:
(F (2,38) = 0.126, p = 0.882)]. Finally, both miR124a-overex-
pressing and -silencing groups of rats did not differ in the
amount of weight lost during the 24 h food deprivation
period (data not shown). The experiments using the non-
stressed control groups are shown in Supplementary Fig. 4.
The data with non-stress controls and stress animals are a
combination of separate experiments, which is far from the
optimal design.
These ﬁndings strongly suggest that decreased and
increased latency to feed were directly related to lower
and higher anxiety levels in siR124a- and miR124a-overex-
pressing rats respectively.
After completion of the NSF test, the same rats were assed
in the sucrose preference test (SPT) using the methodology
described in Section 2 above and results are depicted in Fig. 4C
and D. The groups of rats used were as follow: hippocampus
(LV-Mock n = 7, LV-miR124a n = 9, siR124a n = 8); cortex (LV-
Mock n = 6, LV-miR124a n = 7, siR124a n = 7). Two-way ANOVA
analysis revealed that the average sucrose preference of rats
calculated from measures taken in Mock, siRNA124a and
miR124a-injected groups differed signiﬁcantly from each
other. In fact and as shown in Fig. 4C, there was a signiﬁcant
main effect of viral-injection (F(2,38) = 30.598, p < 0.001) as
well as brain region (F(1,38) = 9.751, p = 0.003) on sucrose
preference. Interestingly, the interaction between the two
factor was highly signiﬁcant (F(2,38) = 43.635, p < 0.001). Post
hoc evaluations indicated that compared to Mock-, miR124a-
expressing rats showed 3 folds decreased sucrose preference
( p < 0.001). In contrast, siR124a-injected rats displayed
higher preference for sucrose (1.3 fold) compared to Mock
control animals ( p = 0.047). During the same test, rats were
then assessed for their total ﬂuid intake and the two-way
ANOVA analysis revealed that no signiﬁcant differences were
observed. As depicted in Fig. 4D, Mock-, siR124a- and miR124a-
injected rats consumed the same amount of ﬂuid during the
SPT. Indeed, there was no main effect of virus (F(2,38) = 0.142,
p = 0.868) and no signiﬁcant main effect of the brain region
(F(1,38) = 0.018, p = 0.894). More importantly, the virus  -
brain region interaction was not signiﬁcant (F(2,38) = 0.284,
p = 0.754). The experiments using the non-stressed control
groups are shown in Supplementary Fig. 5. The data with
non-stress controls and stress animals are a combination of
separate experiments, which is far from the optimal design.
Figure 4 Effect of lentiviral-mediated miR124a modulation on
chronic social defeat-induced depression-like behavior in the
novelty suppressed feeding (NSF) and sucrose preference test
(SPT). (A) Eating delay as measured by the latency to bite food in
a novel anxiogenic environment following 24-h food deprivation,
(B) food intake of rats in the home cage during a 90 min period
following NSF latency test, (C) sucrose preference was calculat-
ed by the following formula: preference = (sucrose solution
intake/total ﬂuid intake)  100. *Signiﬁcant differences be-
tween miR124a or siR124a and Mock ( p < 0.05). #Signiﬁcant
differences between the hippocampus and the cortex
( p < 0.05) (two-way ANOVA, Bonferroni’s post hoc test), and
(D) total ﬂuid intake sucrose intake + water intake. *Signiﬁcant
differences between miR124a or siR124a and Mock ( p < 0.05).
#Signiﬁcant differences between the hippocampus and the cor-
tex ( p < 0.05) (two-way ANOVA, Bonferroni’s post hoc test).
Hippocampus (LV-Mock n = 7, LV-miR124a n = 9, siR124a n = 8);
cortex (LV-Mock n = 6, LV-miR124a n = 7, siR124a n = 7).
Figure 5 Effect of lentiviral-mediated miR124a modulation on
chronic social defeat-induced depression-like behavior in the
forced-swim test (FST). (A) Immobility and (B) swimming. *Sig-
niﬁcant differences between miR124a or siR124a and Mock
( p < 0.05). #Signiﬁcant differences between the hippocampus
and the cortex ( p < 0.05) (two-way ANOVA, Bonferroni’s post
hoc test). Hippocampus (LV-Mock n = 7, LV-miR124a n = 9,
siR124a n = 8); cortex (LV-Mock n = 6, LV-miR124a n = 7, siR124a
n = 7).
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After completion of the SPT, rats were tested in the FST
using these groups of animals: hippocampus (LV-Mock n = 6,
LV-miR124a n = 9, siR124a n = 8); cortex (LV-Mock n = 6,
LV-miR124a n = 7, siR124a n = 7). As depicted in Fig. 5, mod-
ulation of miR124a expression into the hippocampus
profoundly affected FST behavior. In fact, the duration of
immobility was affected following viral-injection
(F(2,38) = 19.285, p < 0.001) but there was no effect of the
brain region (F (1,38) = 0.087, p = 0. 770). Nevertheless, the
viral injection  brain region interaction was highly signiﬁ-
cant (F (2,38) = 24.208, p < 0.001) (Fig. 5A). Post hoc evalua-
tion indicated that miR124a-overexpressing rats were 1.7
fold more immobile than Mock control animals ( p = 0.012). In
contrast and as expected, siR124a-expressing rats were 3
folds less immobile than controls ( p = 0.005). In addition and
as shown in Fig. 5B, the same pattern was also observed when
swimming behavior was assessed in these groups. Thus, the
two-way ANOVA analysis indicated a signiﬁcant main effect of
viral-injection (F(2,38) = 16.586, p < 0.001) and a signiﬁcant
interaction between the brain region and viral-injection
(F(2,38) = 19.466, p < 0.001). Post hoc evaluations revealed
that compared to Mock controls, miR124a spent less time
swimming ( p = 0.071). However, siR124a-expressing rats
were more active in their swimming behavior ( p = 0.003).
The experiments using the non-stressed control groups are
shown in Supplementary Fig. 6. The data with non-stress
controls and stress animals are a combination of separate
experiments, which is far from the optimal design.
4. Discussion
This is the ﬁrst study to demonstrate that exposure to chronic
social defeat stress can induce miR124a expression in the
brain hippocampus, a key brain region associated with
depression-like behavior in rats. In addition and as expected,
the mRNA expression level of BDNF, which is a direct target of
miR124a, was reduced following stress exposure. More
importantly, we showed that viral mediated overexpression
of miR124a in the hippocampus, but not in the cortex, was
pro-depressant. In contrast, BDNF or siR124a overexpression
reduced depression-like behavior in rats. These results indi-
cate that miR124a is a critical regulator for BDNF in rat
hippocampus and we hypothesize consequently that miR124a
might participate in the social defeat stress-induced depres-
sive-like behavior through the regulation of BDNF genetic
expression.
Neurotrophic factors such as BDNF were shown to induce
changes in hippocampal neurogenesis and mediate the neu-
ropathophysiology of depression (Castren et al., 2007; D’Sa
and Duman, 2002; Duman and Monteggia, 2006). To further
clarify the neurochemical impact of chronic stress on hippo-
campal neurotrophic factors expression, we studied mRNA
levels of the BDNF after 21-days social defeat stress. Results
have shown that, after three weeks, stress induced a pro-
nounced decrease in BDNF expression in the hippocampus but
not in the cortex conﬁrming previous reports which found
that chronic restraint or social defeat stress caused down-
regulation of BDNF in the same brain region (Haenisch et al.,
2009). In addition, our ﬁndings are in line with those of
Pizarro and co-workers who found using in situ hybridization,
that a brief (10 min) exposure to intense social stress
signiﬁcantly decreased BDNF mRNA expression in the hippo-
campus and amygdala 24 h after social defeat when com-
pared to control (naive) mice (Pizarro et al., 2004). Also, our
ﬁndings agree with those of Alfonso and colleagues, who had
shown that when mice were subjected to repeated restraint
stress, hippocampal BDNF messengers were down-regulated
as measured by RT-PCR (Alfonso et al., 2006). More impor-
tantly, chronic social defeat stress has also been shown to
decrease expression of hippocampal BDNF (Komatsu et al.,
2011). Finally, it should be notiﬁed that the work performed
in Nestler lab indicated that detailed mRNA analysis of whole
mouse hippocampus revealed that chronic defeat stress
induced an approximately threefold reduction in BDNF mRNA
levels (Tsankova et al., 2006). Therefore, we could demon-
strate that chronic social defeat stress caused brain region
speciﬁc alterations in the expression of BDNF suggesting that
these changes may have implications in brain plasticity and
behavioral changes following social stress.
In an attempt to clarify the impact of microRNA on BDNF
messengers, we assessed the expression of miR124a in the
hippocampus following chronic social defeat stress. Micro-
RNAs are small non-coding RNAs involved in the regulation of
gene expression and protein translation and we hypothesize
that miRNAs may be involved in the regulation of chronic
stress-related genes in general and depression in particular.
Results have shown that reduced BDNF levels were accom-
panied with an increase of miR124a expression after 21-days
social defeat. To the best of our knowledge, we are the ﬁrst
who could demonstrate a negative correlation between
levels of BDNF and the expression of miR124a. Indeed, we
have shown in previous report that BDNF is a direct target of
miR124a (Bahi and Dreyer, 2013; Chandrasekar and Dreyer,
2009). Our ﬁndings are in line with those of O’Connor and co-
workers who found using microarray and RT-PCR, that early-
life stress affected the expression of multiple hippocampal
miRNAs (O’Connor et al., 2013). In fact, using a proﬁling
approach it has been reported that early-life stress affected
the expression of multiple hippocampal miRNAs such as
miR451 (O’Connor et al., 2013). When investigating the
impact of social isolation on genes and associated miRNAs,
a recent study reported that the isolated rats exhibited
higher levels of miR29 and miR203 (Yang et al., 2013).
Importantly, the expression levels of vascular endothelial
growth factor A which is a direct target of these miRNAs,
was strongly and speciﬁcally suppressed (Yang et al., 2013).
In our present study we demonstrate for the ﬁrst time that
chronic social defeat increases miR124a expression, suggest-
ing a potential role for depression-associated gene and
miRNA interactions via modulation of BDNF expression.
Social stress-induced alterations of gene expression in
limbic areas are involved in long-term neuroadaptations
and behavioral impairments (Martinez et al., 2002). Inter-
estingly, a number of reports linked BDNF neurotransmission
in the neuropathophysiology of psychiatric disorders in gen-
eral (Balaratnasingam and Janca, 2012) and depression in
particular (Duman and Monteggia, 2006). Unfortunately, the
molecular mechanism by which BDNF may contribute to
the pro-depressant effect of social stress is still not well
understood. In the current study we have demonstrated that
lentiviral-mediated overexpression of BDNF in the hippo-
campus, but not into the cortex, results in an anti-depressant
like behavior. The current behavioral data are consistent with
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results showing that in male Sprague-Dawley rats, a bilateral
infusion of BDNF (0.25 and 1.0 mg) into the dentate gyrus of
the hippocampus increases the swimming behavior in the FST
and, therefore produces antidepressant-like phenotype
(Shirayama et al., 2002). In addition, Govindarajan and co-
workers reported that genetically modiﬁed mice over-
expressing BDNF in excitatory neurons of the forebrain,
including the hippocampus, displayed improved performance
in the Porsolt FST (Govindarajan et al., 2006). In contrast,
heterozygous (+/) BDNF mice were resistant to the effects
of antidepressants in the FST, indicating that antidepressant-
induced behavioral effects require regular BDNF signaling
(Lindholm et al., 2012; Saarelainen et al., 2003). In addition,
it has been shown using the same mice that, when combined
with a stress exposure, heterozygous depletion of BDNF
resulted in a depressive phenotype in the FST (Duman
et al., 2007).
Moreover, we found that hippocampal miR124a overex-
pression exacerbated stress-induced depression-like beha-
vior. In contrast, inhibition of miR124a signaling in the
hippocampus using a lentiviral-mediated silencer expression
‘‘rescued’’ the anti-depressant effect seen in BDNF-overex-
pressing animals. Therefore, we hypothesize that miR124a
plays a pivotal role in stress-related emotions, by regulating
the inhibitory effects of social defeat stress on hippocampal
BDNF expression. Whatever the underlying mechanisms, our
data demonstrate that siR124a and miR124a exert opposite
effects on hippocampal BDNF messenger levels, and suggest
that the balance between these two factors may play a
crucial role in determining vulnerability to stress pro-depres-
sant like effect. Taken together, we propose that social
defeat stress exposure increases the expression of miR124a
and consequently decreases the expression of BDNF in the
hippocampus. Therefore, these results suggest that miR124a
silencing has an antidepressant-like effect, at least in part by
supporting cell proliferation through the BDNF signaling path-
way.
5. Conclusion
Our study demonstrates that chronic social defeat impairs
depression-like behavior in laboratory animals. The unique
expression pattern of gene—miRNA interactions in the hip-
pocampus of socially defeated mice represents a novel
aspect of the complex regulatory network involved in emo-
tional illnesses. These results suggest that overexpression of
miR124a contributes to chronic social stress induced depres-
sion, partially by suppressing BDNF expression. Considering
the important role of miR124a in emotions-related brain
areas, these results suggest a putative mechanism for chronic
social defeat-induced behavioral impairments through the
modulation of BDNF. The inhibition of BDNF identiﬁed in this
study and others (Bahi and Dreyer, 2013; Chandrasekar and
Dreyer, 2009) may provide a target for future therapeutics
that are directed to tackle psychiatric disorders in general
and depression in particular.
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